Eiki Shitara

567 total citations
23 papers, 368 citations indexed

About

Eiki Shitara is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eiki Shitara has authored 23 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 10 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Eiki Shitara's work include Glycosylation and Glycoproteins Research (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Eiki Shitara is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Eiki Shitara collaborates with scholars based in Japan, Finland and India. Eiki Shitara's co-authors include Yoshio Nishimura, TOMIO TAKEUCHI, Keiichiro Fukumoto, Tetsuji Kametani, Fukiko Kojima, Kozo Shishido, Hayamitsu Adachi, TOMIO TAKEUCHI, Motowo Nakajima and Yoshirō Okami and has published in prestigious journals such as Journal of the American Chemical Society, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

In The Last Decade

Eiki Shitara

21 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiki Shitara Japan 12 281 162 46 36 34 23 368
Anthony Stapon United States 10 116 0.4× 233 1.4× 132 2.9× 33 0.9× 62 1.8× 10 388
Mark G. Charest United States 5 342 1.2× 212 1.3× 161 3.5× 47 1.3× 14 0.4× 5 529
Julianna Serly Hungary 13 93 0.3× 191 1.2× 27 0.6× 10 0.3× 34 1.0× 20 345
TOMIZO NIWA United Kingdom 11 197 0.7× 212 1.3× 127 2.8× 66 1.8× 14 0.4× 14 387
J. I. CIALDELLA United States 13 156 0.6× 264 1.6× 169 3.7× 34 0.9× 37 1.1× 31 484
James Clayton United Kingdom 13 220 0.8× 158 1.0× 171 3.7× 15 0.4× 28 0.8× 26 463
Robert F. Keyes United States 11 147 0.5× 156 1.0× 36 0.8× 18 0.5× 32 0.9× 21 312
Monica H. Palme United States 9 166 0.6× 181 1.1× 98 2.1× 56 1.6× 17 0.5× 9 359
Norio Ezaki United Kingdom 15 218 0.8× 212 1.3× 247 5.4× 49 1.4× 34 1.0× 25 503
Ronald R. Rasmussen United Kingdom 13 259 0.9× 238 1.5× 185 4.0× 57 1.6× 34 1.0× 21 488

Countries citing papers authored by Eiki Shitara

Since Specialization
Citations

This map shows the geographic impact of Eiki Shitara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiki Shitara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiki Shitara more than expected).

Fields of papers citing papers by Eiki Shitara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiki Shitara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiki Shitara. The network helps show where Eiki Shitara may publish in the future.

Co-authorship network of co-authors of Eiki Shitara

This figure shows the co-authorship network connecting the top 25 collaborators of Eiki Shitara. A scholar is included among the top collaborators of Eiki Shitara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiki Shitara. Eiki Shitara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Takashi, et al.. (2016). Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines. The Journal of Antibiotics. 69(6). 440–445. 11 indexed citations
2.
Miura, Tomoaki, et al.. (2010). Novel azalides derived from 16-membered macrolides. III. Azalides modified at the C-15 and 4″ positions: Improved antibacterial activities. Bioorganic & Medicinal Chemistry. 18(7). 2735–2747. 15 indexed citations
3.
Yamamoto, Yasuo, et al.. (2008). Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity. Bioorganic & Medicinal Chemistry Letters. 19(2). 447–450. 2 indexed citations
4.
Yamamoto, Yasuo, et al.. (2007). CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity. Bioorganic & Medicinal Chemistry. 15(19). 6379–6387. 4 indexed citations
5.
Yamamoto, Yasuo, et al.. (2006). Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems. Bioorganic & Medicinal Chemistry. 15(1). 392–402. 15 indexed citations
6.
Takahata, Sho, Yukari Tanaka, Keiko Yamada, et al.. (2005). Therapeutic Effect of ME1036 on Endocarditis Experimentally Induced by Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49(8). 3526–3528. 4 indexed citations
7.
Ida, Takashi, et al.. (2004). In Vitro Activities of ME1036 (CP5609), a Novel Parenteral Carbapenem, against Methicillin-Resistant Staphylococci. Antimicrobial Agents and Chemotherapy. 48(8). 2831–2837. 36 indexed citations
8.
Shitara, Eiki, Yoshio Nishimura, Fukiko Kojima, & TOMIO TAKEUCHI. (2000). gem-Diamine 1-N-iminosugars of l-fucose-type, the extremely potent l-fucosidase inhibitors. Bioorganic & Medicinal Chemistry. 8(2). 343–352. 16 indexed citations
9.
Nishimura, Yoshio, Hayamitsu Adachi, Takahiko Satoh, et al.. (2000). All Eight Stereoisomeric d-Glyconic-δ-lactams:  Synthesis, Conformational Analysis, and Evaluation as Glycosidase Inhibitors. The Journal of Organic Chemistry. 65(16). 4871–4882. 41 indexed citations
10.
11.
Shitara, Eiki, Yoshio Nishimura, Fukiko Kojima, & TOMIO TAKEUCHI. (1999). A facile synthesis of d-glucose-type gem-diamine 1-N-iminosugars: a new family of glucosidase inhibitors. Bioorganic & Medicinal Chemistry. 7(6). 1241–1246. 23 indexed citations
12.
Nishimura, Yoshio, Eiki Shitara, & TOMIO TAKEUCHI. (1999). Enantioselective synthesis of a new family of α-l-fucosidase inhibitors. Tetrahedron Letters. 40(12). 2351–2354. 19 indexed citations
13.
Katano, Kiyoaki, Eiki Shitara, Tomoaki Miura, et al.. (1996). Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists. Bioorganic & Medicinal Chemistry Letters. 6(21). 2601–2606. 7 indexed citations
14.
Kamada, Hitoshi, et al.. (1996). Synthesis of Isomelamines and Isocyanurates and Their Biological Evaluation.. Chemical and Pharmaceutical Bulletin. 44(12). 2314–2317. 10 indexed citations
15.
16.
17.
Shishido, Kozo, et al.. (1986). Total syntheses of (.+-.)-physovenine and (.+-.)-physostigmine. An application of tandem electrocyclic-[3,3]sigmatropic reaction of benzocyclobutenes. The Journal of Organic Chemistry. 51(15). 3007–3011. 43 indexed citations
18.
Nemoto, Hisao, Eiki Shitara, Keiichiro Fukumoto, & Tetsuji Kametani. (1985). ChemInform Abstract: AN AROMATIC VERSION OF CLAISEN REARRANGEMENTS OF ESTER SILYL ENOLATES ‐ A FACILE SYNTHESIS OF 2,3‐DISUBSTITUTED FURANS. Chemischer Informationsdienst. 16(30). 8 indexed citations
19.
Fukumoto, Keiichiro, H. Nomoto, Eiki Shitara, & Tetsuji Kametani. (1985). An Aromatic Version of Claisen Rearrangements of Ester Silyl Enolates — A Facile Synthesis of 2,3-Disubstituted Furans. Heterocycles. 23(3). 549–549. 8 indexed citations
20.
Nemoto, Hideo, et al.. (1985). Aromatic Versions of Claisen Rearrangement of Lactonic Silyl Enolates — A Novel to Furanosesquiterpene Framework. Heterocycles. 23(8). 1911–1911. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony Stapon Breakdown of academic impact, for papers by Mark G. Charest Breakdown of academic impact, for papers by Julianna Serly Breakdown of academic impact, for papers by TOMIZO NIWA Breakdown of academic impact, for papers by J. I. CIALDELLA Breakdown of academic impact, for papers by James Clayton Breakdown of academic impact, for papers by Robert F. Keyes Breakdown of academic impact, for papers by Monica H. Palme Breakdown of academic impact, for papers by Norio Ezaki Breakdown of academic impact, for papers by Ronald R. Rasmussen
Rankless by CCL
2026